Key statistics
As of last trade, Bruker Corp (BRKR:NSQ) traded at 56.85, 18.27% above the 52 week low of 48.07 set on Nov 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 56.24 |
---|---|
High | 57.56 |
Low | 56.17 |
Bid | 56.81 |
Offer | 56.89 |
Previous close | 56.22 |
Average volume | 1.78m |
---|---|
Shares outstanding | 151.60m |
Free float | 103.23m |
P/E (TTM) | 27.11 |
Market cap | 8.52bn USD |
EPS (TTM) | 2.07 USD |
Annual div (ADY) | 0.20 USD |
---|---|
Annual div yield (ADY) | 0.36% |
Div ex-date | Aug 30 2024 |
Div pay-date | Sep 16 2024 |
Next div ex-date | Dec 02 2024 |
Next div pay-date | Dec 16 2024 |
Data delayed at least 15 minutes, as of Nov 22 2024 19:55 GMT.
More ▼
- Bruker Announces Quarterly Dividend
- Bruker Corporation to Present at Upcoming Investor Conferences
- Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
- Bruker Reports Third Quarter 2024 Financial Results
- Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
- Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
- European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
- Bruker Announces Formation of New Bruker Spatial Biology Division
- Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
- Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
More ▼